47.69
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Harrow Inc Aktie (HROW) Neueste Nachrichten
Can Harrow Inc. expand into new markets2025 Market Trends & Weekly Top Gainers Alerts - mfd.ru
Precision Trading with Harrow Health Inc. 8.625% Senior Notes Due 2026 (HROWL) Risk Zones - Stock Traders Daily
Loss Report: What are the future prospects of Harrow IncQuarterly Growth Report & Fast Gain Stock Tips - baoquankhu1.vn
Will Harrow Inc. stock attract more institutional investorsWeekly Trade Report & Weekly High Return Stock Forecasts - mfd.ru
Harrow, Inc. (HROW) Stock Analysis: A 48% Upside in the Promising Ophthalmic Pharmaceuticals Sector - DirectorsTalk Interviews
Is Harrow’s (HROW) Reaffirmed 2025 Guidance Quietly Redefining Its Ophthalmic Growth Strategy? - simplywall.st
Harrow Refocuses After ImprimisRx Exit As New CCO Takes Charge - Sahm
A Look At Harrow’s (HROW) Valuation As 2025 Guidance Is Reaffirmed And Regulatory Issues Clear - Yahoo Finance
New York State Common Retirement Fund Raises Stock Position in Harrow, Inc. $HROW - MarketBeat
B.Riley reiterates Buy rating on Harrow Health stock amid VEVYE growth - Investing.com
Harrow (NASDAQ:HROW) Downgraded by Zacks Research to "Hold" - MarketBeat
Growth Recap: Should I hold or sell Harrow Inc now2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - baoquankhu1.vn
Harrow Reaffirms FY2025 Revenue Growth Range Of 35% To 40%; Expands Sales Force - Nasdaq
Harrow Stock (+9.7%): Commercial Expansion Ignites Institutional Buying - Trefis
Strength Seen in Harrow (HROW): Can Its 9.7% Jump Turn into More Strength? - Nasdaq
Rival quits California market; OSRX steps in to keep eye meds flowing - stocktitan.net
How Harrow Health Inc. (HROW) Affects Rotational Strategy Timing - Stock Traders Daily
Harrow on track to double sales force, expand product reach By Investing.com - Investing.com Nigeria
OSRX Continues Support in California Market After Competitor Exit - Intellectia AI
Harrow (NASDAQ:HROW) Shares Gap UpShould You Buy? - MarketBeat
Harrow on track to double sales force, expand product reach - Investing.com
(HROW) Harrow Expects 2025 Revenue Range $270M$280M, vs. FactSet Est of $273.4M - marketscreener.com
Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth - marketscreener.com
Is Harrow Inc. attractive for institutional investors2025 Winners & Losers & Verified Momentum Stock Alerts - Mfd.ru
Harrow Becomes Oversold (HROW) - Nasdaq
Can Harrow Inc. be recession proofJuly 2025 Rallies & Daily Volume Surge Signals - mfd.ru
Risk Report: Is PMTV stock showing strong momentum2025 Price Targets & Low Volatility Stock Recommendations - baoquankhu1.vn
109,421 Shares in Harrow, Inc. $HROW Acquired by Blackhawk Capital Partners LLC - MarketBeat
Harrow, Inc. (NASDAQ:HROW) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update (NASDAQ:HROW) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Down 4.4%Time to Sell? - MarketBeat
Market Trends: Can Harrow Inc expand into new marketsJuly 2025 Drop Watch & AI Enhanced Execution Alerts - baoquankhu1.vn
Pharma News: Can Harrow Inc. be recession proofTrade Risk Assessment & Weekly High Return Stock Forecasts - baoquankhu1.vn
Investment Recap: Can OptimizeRx Corporation weather a recessionQuarterly Trade Review & Weekly Setup with ROI Potential - baoquankhu1.vn
Breakeven Is Near for Harrow, Inc. (NASDAQ:HROW) - Yahoo Finance
Assessing Harrow (HROW) Valuation After Its Shift To An Integrated U.S. Eye Care Pharma Platform - Sahm
LJI Wealth Management LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat
Opaleye management sells $711,814 worth of Harrow shares - MSN
Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN
Harrow, Inc. (NASDAQ:HROW) Could Be Less Than A Year Away From Profitability - 富途资讯
Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength - sharewise.com
Harrow, Inc. (HROW): A Bull Case Theory - Finviz
Zacks Research Upgrades Harrow (NASDAQ:HROW) to "Strong-Buy" - MarketBeat
Gap Down: Can Harrow Inc maintain sales growthBull Run & Safe Capital Allocation Plans - baoquankhu1.vn
Harrow: Flirting With Missing 2025 Revised Guidance (NASDAQ:HROW) - Seeking Alpha
Value Recap: Will Harrow Inc benefit from geopolitical trendsWeekly Trend Summary & Weekly Momentum Stock Picks - baoquankhu1.vn
Responsive Playbooks and the HROW Inflection - Stock Traders Daily
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):